🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Non-Interventional Study on the Tolerability and Efficacy of octagam® 10%...
Status
Completed
Location
Octapharma Research Site
Start Date
2011-08-01
Trial ID
NCT02303093
Treatments Being Tested
Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophy...
Status
Completed
Location
Octapharma Research Site
Start Date
2020-10-05
Trial ID
NCT04502030
This randomized phase III trial is studying cyclophosphamide, prednisone, a...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2004-03-15
Trial ID
NCT00033293
Study to evaluate the Efficacy and Safety of Three Different Dosages of New...
Status
Completed
Location
MHAT Puls EOOD
Start Date
2017-09-27
Trial ID
NCT02638207
Treatments Being Tested
A Superiority Study To Compare The Effect of Panzyga Versus Placebo in Pati...
Status
Completed
Location
Octapharma Research Site
Start Date
2021-06-30
Trial ID
NCT04508530
Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic...
Status
Recruiting
Location
Octapharma Research Site
Start Date
2023-10-01
Trial ID
NCT04929236
Treatments Being Tested
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study ...
Status
Recruiting
Location
Perseverance Research Center, Phoenix Neurological Associates
Start Date
2026-06-10
Trial ID
NCT07220915
Treatments Being Tested
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a treatable for...
Status
Unknown
Location
UHNToronto
Start Date
2017-06-01
Trial ID
NCT03166527
Treatments Being Tested
This study will enroll patients with small fiber neuropathy (SFN). The stud...
Status
Recruiting
Location
Endeavor Health
Start Date
2023-12-15
Trial ID
NCT04153422
Treatments Being Tested
This is a prospective, open-label, single-arm, multicenter, Phase 4 study e...
Status
Terminated
Location
Octapharma Research Site
Start Date
2020-01-21
Trial ID
NCT03866798
Treatments Being Tested